
This study describes the advances of European left ventricular assist devices (LVADs) programmes from the PCHF‐VAD registry across device implantation eras. Of 583 patients from 13 European centres in the registry, 556 were eligible for this analysis. In an analysis depicting the evolving landscape of continuous‐flow LVAD carriers in Europe over 13 years, a trend towards better survival was seen in recent years, despite older recipients with more comorbidities, potentially attributable to increasing expertise of LVAD centres, improved patient selection and pump technology.
Like
Save
Share